Negative biopsies among early-stage prostate cancer patients who've chosen active surveillance are associated with a low risk of disease progression, but they aren't a sign that their cancer has completely vanished, a new study indicates.
Active surveillance refers to close monitoring for signs of cancer progression -- what's often called "watchful waiting." Patients sometimes get regula...
A 'watchful waiting' approach to care may be safe for Black Americans with low-risk prostate cancer, a new study suggests.
Black patients are less likely than whites to be offered watchful waiting, also called active surveillance. This may be because compared to whites, Black men are more likely to have aggressive prostate cancer and 2.4 times more likely to die from the disease.
While men can take solace in a new government report that shows prostate cancer cases have been declining overall in the past two decades, the same analysis finds that the opposite is true for advanced prostate cancer cases.
In fact, the number of cases of cancer that had already spread from the prostate to other parts of the body doubled between 2003 and 2017, going from 4% to 8&...
Prostate cancer screening guidelines have been evolving for more than a decade, but new research suggests that recommendations against routine prostate cancer testing may have come at a steep price -- more men getting diagnosed with advanced prostate cancers.
The study found that rates of advanced prostate cancers rose by about 5% per year through 2016.
"Watchful waiting" is on the rise overall among U.S. men with low-risk prostate cancer, but black men remain less likely to opt for it, a new study finds.
For the study, researchers examined 2010-2015 data on more than 50,000 low-risk prostate cancer patients in the United States. The investigators found that black men were 16% less likely than other men to decide on watchful wai...